Cite
HARVARD Citation
Hajek, R. et al. (2020). A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. European journal of haematology. pp. 435-442. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hajek, R. et al. (2020). A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. European journal of haematology. pp. 435-442. [Online].